Elon Musk's brain-implant company Neuralink said the U.S. Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
Tạp chí Nhịp Cầu Đầu Tư
151 ngày
